SCHEMBL593554

SCHEMBL593554

CC(=O)OCCC(=O)n1cnc2ccccc21

nearest known ligand 0.48

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.48
SMN1; SMN2 Q16637 4/20 0.47
MAPT P10636 2/20 0.46
HSD17B10 Q99714 2/20 0.46
NPC1 O15118 1/20 0.46
ALDH1A1 P00352 1/20 0.46
HPGD P15428 1/20 0.46
RAB9A P51151 1/20 0.46
ASAH1 Q13510 6/20 0.46
MEN1 O00255 1/20 0.45
HTT P42858 2/20 0.44
EGLN3 Q9H6Z9 1/20 0.43
LMNA P02545 1/20 0.42
STAT6 P42226 1/20 0.42
POLB P06746 1/20 0.42
ALOX15 P16050 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7790594 0.78 ASAH1 (0.51) KMT2ASMN1; SMN2MAPTHSD17B10NPC1
SCHEMBL1735988 0.78 ASAH1 (0.55) KMT2ASMN1; SMN2MAPTHSD17B10NPC1
SCHEMBL11012986 0.77 NPC1 (0.57) KMT2ASMN1; SMN2MAPTHSD17B10NPC1
SCHEMBL502049 0.77 SMN1; SMN2 (0.66) KMT2ASMN1; SMN2MAPTRAB9AMEN1
SCHEMBL17322551 0.77 EGLN3 (0.51) KMT2ASMN1; SMN2MAPTHSD17B10NPC1
SCHEMBL1003201 0.76 SMN1; SMN2 (0.45) KMT2ASMN1; SMN2MAPTHSD17B10NPC1
SCHEMBL13092517 0.76 ASAH1 (0.66) KMT2ASMN1; SMN2MAPTHSD17B10NPC1
SCHEMBL13092515 0.76 ASAH1 (0.66) KMT2ASMN1; SMN2MAPTHSD17B10NPC1
SCHEMBL7132708 0.76 ASAH1 (0.55) KMT2ASMN1; SMN2MAPTHSD17B10NPC1
SCHEMBL3078847 0.75 SMN1; SMN2 (0.59) KMT2ASMN1; SMN2MAPTHSD17B10NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2033966-B1 Novel photoacid generators, resist compositons, and patterning processes SHINETSU CHEMICAL CO (JP) 2015-07-29 EP disclosed
US-8114571-B2 Photoacid generator, resist composition, and patterning process SHIN-ETSU CHEMICAL CO., LTD. (JP) 2012-02-14 US disclosed
US-8062831-B2 Carboxyl-containing lactone compound, polymer, resist composition, and patterning process SHIN-ETSU CHEMICAL CO., LTD. (JP) 2011-11-22 US disclosed
US-7670751-B2 Photoacid generator, resist composition, and patterning process SHIN-ETSU CHEMICAL CO., LTD. (JP) 2010-03-02 US disclosed
US-20090274978-A1 NOVEL PHOTOACID GENERATOR, RESIST COMPOSITION, AND PATTERNING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2009-11-05 US disclosed
US-20090274984-A1 CARBOXYL-CONTAINING LACTONE COMPOUND, POLYMER, RESIST COMPOSITION, AND PATTERNING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2009-11-05 US disclosed
EP-2033966-A2 Movel photoacid generators, resist compositons, and patterning processes Shin-Etsu Chemical Co., Ltd. (JP) 2009-03-11 EP disclosed
US-20090061358-A1 NOVEL PHOTOACID GENERATOR, RESIST COMPOSITION, AND PATTERNING PROCESS PROXIMAL SYSTEMS CORPORATION 2009-03-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090061358-A1 NOVEL PHOTOACID GENERATOR, RESIST COMPOSITION, AND PATTERNING PROCESS RER1, CRY1, CYP21A2 KMT2A 3509/4885SMN1; SMN2 4173/4885MAPT 4545/4885
US-20090274984-A1 CARBOXYL-CONTAINING LACTONE COMPOUND, POLYMER, RESIST COMPOSITION, AND PATTERNING PROCESS WDR1, EGLN1, RER1 KMT2A 463/4885SMN1; SMN2 3853/4885MAPT 4208/4885
US-20090274978-A1 NOVEL PHOTOACID GENERATOR, RESIST COMPOSITION, AND PATTERNING PROCESS CYP21A2, C1S, C1R KMT2A 2308/4885SMN1; SMN2 4504/4885MAPT 4584/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.